TRNS Stock Summary and Trading Ideas (Transcat | NASDAQ:TRNS)

Transcat Inc is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing services and products to high regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical devices, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. It conducts business through two operating segments: Services and Distribution.

Transcat trades on the NASDAQ stock market under the symbol TRNS.

As of September 8, 2026, TRNS stock price declined to $83.74 with 52,374 million shares trading.

TRNS has a beta of 1.40, meaning it tends to be more sensitive to market movements. TRNS has a correlation of 0.11 to the broad based SPY ETF.

TRNS has a market cap of $783.79 million. This is considered a Small Cap stock.

Last quarter Transcat reported $93 million in Revenue and $.51 earnings per share. This beat revenue expectation by $6 million and exceeded earnings estimates by $.13.

In the last 3 years, TRNS traded as high as $147.12 and as low as $50.23.

The top ETF exchange traded funds that TRNS belongs to (by Net Assets): VTI, IWM, TSME, VXF, VTWO.

TRNS has underperformed the market in the last year with a price return of +7.8% while the SPY ETF gained +19.2%. TRNS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -10.2% and -9.5%, respectively, while the SPY returned +1.4% and 0.0%, respectively.

TRNS support price is $82.98 and resistance is $87.98 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TRNS shares will trade within this expected range on the day.